{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T13:27:15Z","timestamp":1783085235878,"version":"3.54.6"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T00:00:00Z","timestamp":1761264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T00:00:00Z","timestamp":1761264000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cytogenet"],"DOI":"10.1186\/s13039-025-00733-4","type":"journal-article","created":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T14:26:38Z","timestamp":1761315998000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Rare case of PLAG1::RUNX1 fusion mimicking classical t(8;21): the value of optical genome mapping in acute myeloid leukemia"],"prefix":"10.1186","volume":"18","author":[{"given":"Nada","family":"Assaf","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shireen","family":"Alawieh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rawan","family":"Hammoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agn\u00e8s","family":"Daudignon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Luquet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliette","family":"Lambert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Terr\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,24]]},"reference":[{"key":"733_CR1","unstructured":"Swerdlow SH. WHO classification of tumors of hematopoietic and lymphoid tissues. revised 4th edition ed. 2017: WHO."},{"issue":"1","key":"733_CR2","doi-asserted-by":"publisher","first-page":"77","DOI":"10.2217\/fon.10.158","volume":"7","author":"E De Braekeleer","year":"2011","unstructured":"De Braekeleer E, Douet-Guilbert N, Morel F, Le Bris MJ, Ferec C, De Braekeleer M. RUNX1 translocations and fusion genes in malignant hemopathies. Future Oncol. 2011;7(1):77\u201391.","journal-title":"Future Oncol"},{"issue":"2","key":"733_CR3","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1002\/gcc.22901","volume":"60","author":"U Aypar","year":"2021","unstructured":"Aypar U, Yao J, Londono DM, Khoobyar R, Scalise A, Arcila ME, et al. Rare and novel RUNX1 fusions in myeloid neoplasms: a single-institute experience. Genes Chromosomes Cancer. 2021;60(2):100\u20137.","journal-title":"Genes Chromosomes Cancer"},{"issue":"5","key":"733_CR4","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1038\/s41375-017-0002-z","volume":"32","author":"A Stengel","year":"2018","unstructured":"Stengel A, Nadarajah N, Haferlach T, Dicker F, Kern W, Meggendorfer M, et al. Detection of recurrent and of novel fusion transcripts in myeloid malignancies by targeted RNA sequencing. Leukemia. 2018;32(5):1229\u201338.","journal-title":"Leukemia"},{"issue":"7","key":"733_CR5","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1182\/bloodadvances.2022007583","volume":"7","author":"B Levy","year":"2023","unstructured":"Levy B, Baughn LB, Akkari Y, Chartrand S, LaBarge B, Claxton D, et al. Optical genome mapping in acute myeloid leukemia: a multicenter evaluation. Blood Adv. 2023;7(7):1297\u2013307.","journal-title":"Blood Adv"},{"key":"733_CR6","doi-asserted-by":"crossref","unstructured":"ISCN 2024 - An International System for Human Cytogenomic Nomenclature. (2024). Cytogenet Genome Res. 2024;164(Suppl 1):1-224.","DOI":"10.1159\/000538512"},{"issue":"3","key":"733_CR7","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1038\/leu.2015.177","volume":"30","author":"P Ruminy","year":"2016","unstructured":"Ruminy P, Marchand V, Buchbinder N, Larson T, Joly B, Penther D, et al. Multiplexed targeted sequencing of recurrent fusion genes in acute leukaemia. Leukemia. 2016;30(3):757\u201360.","journal-title":"Leukemia"},{"key":"733_CR8","doi-asserted-by":"publisher","DOI":"10.3390\/jpm14030291","author":"L Budurlean","year":"2024","unstructured":"Budurlean L, Tukaramrao DB, Zhang L, Dovat S, Broach J. Integrating optical genome mapping and whole genome sequencing in somatic structural variant detection. J Pers Med. 2024;14(3):291. https:\/\/doi.org\/10.3390\/jpm14030291.","journal-title":"J Pers Med"},{"issue":"7","key":"733_CR9","doi-asserted-by":"publisher","first-page":"2900","DOI":"10.1182\/blood-2004-09-3630","volume":"105","author":"SF Landrette","year":"2005","unstructured":"Landrette SF, Kuo YH, Hensen K, van Barjesteh S, Perrat PN, Van de Ven WJ, et al. Plag1 and Plagl2 are oncogenes that induce acute myeloid leukemia in cooperation with Cbfb-MYH11. Blood. 2005;105(7):2900\u20137.","journal-title":"Blood"},{"key":"733_CR10","doi-asserted-by":"crossref","unstructured":"Van Dyck F, Declercq J, Braem C, Van de Ven W. PLAG1, the prototype of the PLAG gene family: versatility in tumour development (Review). Int J Oncol. 2007;30(4):765\u201374.","DOI":"10.3892\/ijo.30.4.765"},{"issue":"5","key":"733_CR11","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1038\/s41588-021-00829-8","volume":"53","author":"Z Gu","year":"2021","unstructured":"Gu Z, Liu Y, Zhang Y, Cao H, Lyu J, Wang X, et al. Silencing of LINE-1 retrotransposons is a selective dependency of myeloid leukemia. Nat Genet. 2021;53(5):672\u201382.","journal-title":"Nat Genet"},{"issue":"10","key":"733_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2022.e11093","volume":"8","author":"A Salavaty","year":"2022","unstructured":"Salavaty A, Shehni SA, Ramialison M, Currie PD. Systematic molecular profiling of acute leukemia cancer stem cells allows identification of druggable targets. Heliyon. 2022;8(10):e11093.","journal-title":"Heliyon"},{"issue":"8","key":"733_CR13","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1016\/j.ajhg.2021.06.001","volume":"108","author":"K Neveling","year":"2021","unstructured":"Neveling K, Mantere T, Vermeulen S, Oorsprong M, van Beek R, Kater-Baats E, et al. Next-generation cytogenetics: comprehensive assessment of 52 hematological malignancy genomes by optical genome mapping. Am J Hum Genet. 2021;108(8):1423\u201335.","journal-title":"Am J Hum Genet"},{"issue":"12","key":"733_CR14","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1016\/j.jmoldx.2022.09.009","volume":"24","author":"NS Sahajpal","year":"2022","unstructured":"Sahajpal NS, Mondal AK, Tvrdik T, Hauenstein J, Shi H, Deeb KK, et al. Clinical validation and diagnostic utility of optical genome mapping for enhanced cytogenomic analysis of hematological neoplasms. J Mol Diagn. 2022;24(12):1279\u201391.","journal-title":"J Mol Diagn"},{"key":"733_CR15","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15061684","author":"V Nilius-Eliliwi","year":"2023","unstructured":"Nilius-Eliliwi V, Gerding WM, Schroers R, Nguyen HP, Vangala DB. Optical genome mapping for cytogenetic diagnostics in AML. Cancers (Basel). 2023;15(6):1684. https:\/\/doi.org\/10.3390\/cancers15061684.","journal-title":"Cancers (Basel)"},{"issue":"9","key":"733_CR16","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1038\/s41408-022-00718-1","volume":"12","author":"E Balducci","year":"2022","unstructured":"Balducci E, Kaltenbach S, Villarese P, Duroyon E, Zalmai L, Friedrich C, et al. Optical genome mapping refines cytogenetic diagnostics, prognostic stratification and provides new molecular insights in adult MDS\/AML patients. Blood Cancer J. 2022;12(9):126.","journal-title":"Blood Cancer J"}],"container-title":["Molecular Cytogenetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13039-025-00733-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13039-025-00733-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13039-025-00733-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T14:26:43Z","timestamp":1761316003000},"score":1,"resource":{"primary":{"URL":"https:\/\/molecularcytogenetics.biomedcentral.com\/articles\/10.1186\/s13039-025-00733-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,24]]},"references-count":16,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["733"],"URL":"https:\/\/doi.org\/10.1186\/s13039-025-00733-4","relation":{},"ISSN":["1755-8166"],"issn-type":[{"value":"1755-8166","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,24]]},"assertion":[{"value":"16 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Institutional Review Board at the American University of Beirut exempted our single case report from review.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Patient\u2019s informed consent was obtained for anonymous publication of her case.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Patient consent statement"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"29"}}